Oie LR, Wergeland T, Salvesen O, Gravdahl GRB, et al. Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. Lancet Neurol 2025;24:817-827.
PMID: 40975098